NCT02040558View on ClinicalTrials.gov

Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

July 31, 2016

Conditions
Advanced Solid Tumors
Interventions
DRUG

MNK-010

Trial Locations (1)

02215

Dana Farber Cancer Institute, Boston

Sponsors

Lead Sponsor

Mallinckrodt
All Listed Sponsors
lead

Mallinckrodt

INDUSTRY

NCT02040558 - Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid Tumors | Biotech Hunter | Biotech Hunter